FKBP5 rs7748266: Stress Response and Treatment Response
The rs7748266 variant is a common genetic change located within the FKBP5 gene, which plays a critical role in regulating the body's stress response system. Research suggests this variant may influence how individuals respond to stressful life events and the effectiveness of lithium treatment in bipolar disorder.
What each genotype means
Typical stress response profile
This genotype is associated with typical regulation of the HPA axis, which manages the body's response to stress. Research suggests that individuals with this genotype may have different outcomes regarding lithium treatment efficacy and susceptibility to stress-related conditions compared to those carrying the T allele. Please discuss any concerns regarding medication response or mental health with your clinician.
This is a common genotype found in many global populations.
Altered stress response sensitivity
Carrying one copy of the T allele has been associated with variations in how the body responds to stress and potential differences in lithium treatment effectiveness for bipolar disorder. Some studies also link this genotype to an increased risk of ADHD symptoms in certain populations. Because these associations can be influenced by environmental factors like early life stress, please consult your healthcare provider to discuss your specific health context.
This heterozygous genotype is frequently observed across diverse ancestral groups.
Increased stress response sensitivity
The T allele is associated with altered HPA axis function, which may influence how you respond to stressful situations and certain psychiatric treatments, including lithium. Research has linked this genotype to increased susceptibility to depressive symptoms and ADHD in some studies, though these effects often depend on environmental interactions. Always consult with your pharmacist or physician before making changes to your medication regimen.
This genotype is present in the general population, though its frequency varies significantly by ancestry.
Understanding the rs7748266 Variant
The rs7748266 variant is a single-nucleotide polymorphism (SNP) found within the FKBP5 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is located in a region of the genome that helps control the expression of the FKBP5 protein. Because this gene is deeply involved in the hypothalamic-pituitary-adrenal (HPA) axis—the body's primary system for managing stress—researchers have long been interested in how variations here might alter physiological responses to environmental challenges. By studying this SNP, scientists aim to understand why individuals differ in their biological reactions to stress and their subsequent susceptibility to mood-related conditions.
The Role of the FKBP5 Gene
The FKBP5 gene provides instructions for making a protein called FKBP51. This protein acts as a regulator of the glucocorticoid receptor, which is essential for the body to 'turn off' the stress response once a threat has passed. When FKBP51 levels are altered, it can disrupt the negative feedback loop of the HPA axis, potentially leading to prolonged or heightened cortisol levels. Because the HPA axis is central to mood regulation, variations in FKBP5 are frequently studied in the context of psychiatric health. By modulating how the body senses and responds to glucocorticoids, the FKBP5 gene serves as a bridge between genetic predisposition and the physiological impact of life experiences.
Research Associations and Evidence Strength
Evidence for rs7748266 is considered moderate and context-dependent. Some studies have identified an association between this variant and the effectiveness of lithium treatment in patients with bipolar disorder, suggesting that specific genotypes may correlate with better or worse clinical responses. Additionally, research has explored how rs7748266 interacts with early-life stress to influence amygdala reactivity and the development of depressive symptoms. However, findings are not always consistent across different populations or study designs. For instance, while some studies report significant correlations with cortisol levels or treatment outcomes, others have found no clear association in different ethnic groups or clinical cohorts. This variability highlights that genetic influence is rarely absolute and often depends on the interplay between genetics, environment, and individual clinical history.
Population Frequency
The rs7748266 variant is considered a common polymorphism, meaning it is found frequently across diverse human populations. While specific allele frequencies can vary by ancestry, it is widely present in global genetic databases, making it a standard marker in studies investigating HPA axis function.
What This Information Means for You
It is important to understand that genetic variants like rs7748266 do not determine your health outcomes on their own. They represent small pieces of a much larger puzzle that includes your environment, lifestyle, and other genetic factors. You cannot use this information to diagnose a condition or predict a specific response to medication. If you are currently taking lithium or other medications for a mood disorder, do not make any changes to your treatment plan based on genetic data. Always discuss your genetic results with your clinician or pharmacist, as they can interpret these findings within the context of your overall health, medical history, and current treatment goals.
How common is this variant?
The rs7748266 variant is common across global populations, with allele frequencies typically ranging significantly depending on ancestral background.
Frequently asked questions
Can I use rs7748266 to predict if lithium will work for me?
No. While some research suggests an association between this variant and lithium response, it is not a definitive diagnostic tool. Medication effectiveness is complex and depends on many factors that only your doctor can evaluate.
Does having the 'risk' genotype mean I will develop depression?
No. Genetic variants only indicate a potential predisposition. Many people with this genotype never develop depression, and many without it do, as environmental factors and other genes play a major role.
Should I change my medication based on my FKBP5 results?
Absolutely not. Never alter your medication dosage or stop taking prescribed treatments without consulting your healthcare provider. Genetic information should only be used as a supplement to professional medical advice.
What is the HPA axis and why does FKBP5 matter?
The HPA axis is your body's stress-response system. FKBP5 helps regulate this system by controlling how your body responds to stress hormones, which is why it is a focus of research in mood disorders.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7748266?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
Associated with decreased cortisol suppression, this variant indicates a potential role in altered HPA axis negative feedback mechanisms.
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.